China / Pharma Market Growth 2016-2025
The Chinese pharma market grew by eight percent from 2016 to 2018, slowed to four percent between 2018 and 2022 in part thanks to the introduction of volume-based procurement (VBP),…
The Chinese pharma market grew by eight percent from 2016 to 2018, slowed to four percent between 2018 and 2022 in part thanks to the introduction of volume-based procurement (VBP),…
The top 10 Chinese pharma companies for 2022, ranked by sales value and based on data from the latest Forbes Global 2000 ranking. Big conglomerates like Sinopharm, Shanghai Pharmaceuticals, and…
The latest reporting on China biopharma dealmaking from MSQ Ventures, including the Top 10 biotech in-licensing deals in H1 2021, the Top 5 out-licensing deals, and Top 10 IPOs. …
The Top 10 Chinese pharma companies for 2020 ranked by overall revenues. Taken from Fortune magazine’s 2020 list of the 500 biggest companies in China, this up-to-date list shows Shanghai…
The Chinese NMPA’s drug approval list for 2020 includes a surge in approvals for locally developed drugs. A total of 46 new drugs were approved in 2020 (less than the…
While many parts of the world ground to a halt as they tried to deal with the global pandemic, China had more or less brought the situation under control by…
Biosimilars are a relatively recent development in the pharmaceutical industry, meaning market penetration is still fairly low, even in many developed markets, much less emerging markets. Prior to 2019, not…
These ten Chinese pharma companies ranked by 2018 revenues, each brought in more than a billion US dollars. Sinopharm comes out on top with revenues of USD 48.5 billion. Made…
China has expanded to be the second largest pharmaceutical market globally with USD 137 billion in total spending in 2018, but growth has slowed from a 19% CAGR in 2008–2013…
The Greater Bay Area (several cities in Guangdong Province in mainland China along with Hong Kong and Macau) is a major Chinese government scheme to link the entire region into…
India leads the way in terms of the sheer volume of US FDA-approved manufacturing plants with over 100, compared to only 28 in China. In terms of the global competitiveness…
See our Cookie Privacy Policy Here